Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00295932
Status:
COMPLETED
Last Update Posted:
2018-11-20
First Post:
2006-02-23
Brief Title:
Bortezomib Rituximab Cyclophosphamide and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkins Lymphoma
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center